|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention relates to a method for producing a stable, high-purity, crystalline form of a compound.
|
|
gptkbp:applicationNumber
|
10/123,456
|
|
gptkbp:assignee
|
gptkb:Acme_Corporation
|
|
gptkbp:associatedWith
|
EP_0201234
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:fieldOfInvention
|
Pharmaceuticals
|
|
gptkbp:hasCitations
|
gptkb:US_5,678,910_A
|
|
gptkbp:hasCollaborationsWith
|
gptkb:University_of_Science
|
|
gptkbp:hasCollection
|
No
|
|
gptkbp:hasCompetitors
|
Competing Drug Y
|
|
gptkbp:hasContribution
|
High
Pharmacies
Dedicated Team
|
|
gptkbp:hasDescription
|
The invention provides a method for producing a stable crystalline form.
|
|
gptkbp:hasExaminer
|
Jane_Smith
|
|
gptkbp:hasFacility
|
US_6,789,969_C19_Family
|
|
gptkbp:hasFeature
|
Positive
Paid
|
|
gptkbp:hasFieldOfUse
|
Medicinal Applications
|
|
gptkbp:hasFigures
|
5
|
|
gptkbp:hasFilingDate
|
April 1, 2003
|
|
gptkbp:hasFilm
|
Worldwide
Minimal
|
|
gptkbp:hasFunding
|
Government_Grant
|
|
gptkbp:hasFuturePlans
|
Expansion
|
|
gptkbp:hasGoals
|
Yes
|
|
gptkbp:hasImpactOn
|
High
|
|
gptkbp:hasInternationalClassification
|
A61K 31/00
514/123
|
|
gptkbp:hasInventor
|
gptkb:Alice_Johnson
|
|
gptkbp:hasLegalStatus
|
Active
Licensed
|
|
gptkbp:hasLocalCuisine
|
Completed
|
|
gptkbp:hasOccupation
|
Yes
FDA_Approved
|
|
gptkbp:hasPartnershipsWith
|
gptkb:Pharma_Inc.
|
|
gptkbp:hasPerformedAt
|
Tablet
|
|
gptkbp:hasPopulation
|
Adults
|
|
gptkbp:hasPriorityDate
|
September 14, 2004
September 14, 2024
|
|
gptkbp:hasProductLine
|
Crystalline_Compound_X
|
|
gptkbp:hasPrograms
|
Well-Studied
|
|
gptkbp:hasPublications
|
2004/0123456 A1
|
|
gptkbp:hasRelatedPatent
|
gptkb:US_6,789,970_C20
Incremental Innovation
|
|
gptkbp:hasResearchInterest
|
Conducted
Pharmaceutical_Research
|
|
gptkbp:hasSpecialty
|
Direct_Marketing
|
|
gptkbp:hasTechnicalField
|
Organic Chemistry
|
|
gptkbp:hasTechnology
|
Yes
|
|
gptkbp:hasTitle
|
Method for producing a stable, high-purity, crystalline form of a compound
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,969 C19
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:issuedOn
|
September 14, 2004
|
|
gptkbp:market
|
2005
Large
Premium
Commercialized
|
|
gptkbp:priorityDate
|
March 1, 2002
|
|
gptkbp:provides
|
Oncology
|
|
gptkbp:relatedTo
|
gptkb:US_6,789,968_C18
|
|
gptkbp:route
|
Oral
|